Point72 Asset Management Portfolio holdings
AUM
$42.3B
1-Year Return
23.07%
This Quarter Return
-1.61%
1 Year Return
+23.07%
3 Year Return
+96.14%
5 Year Return
+182.48%
10 Year Return
+383.75%
AUM
$29.4B
AUM Growth
+$431M
(+1.5%)
Cap. Flow
+$1.04B
Cap. Flow
% of AUM
3.54%
Top 10 Holdings %
Top 10 Hldgs %
13.49%
Holding
2,326
New
613
Increased
589
Reduced
429
Closed
466
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
+$278M |
| 2 |
Arista Networks
ANET
|
+$213M |
| 3 |
Boeing
BA
|
+$204M |
| 4 |
Qiagen
QGEN
|
+$177M |
| 5 |
Kenvue
KVUE
|
+$166M |
Top Sells
| 1 |
Adobe
ADBE
|
+$355M |
| 2 |
AutoZone
AZO
|
+$242M |
| 3 |
Dominion Energy
D
|
+$186M |
| 4 |
Palo Alto Networks
PANW
|
+$185M |
| 5 |
Marathon Petroleum
MPC
|
+$183M |
Sector Composition
| 1 | Technology | 20.26% |
| 2 | Healthcare | 19.48% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Industrials | 10.26% |
| 5 | Energy | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Gentex
GNTX
$6.15B
| $3.47M | 0.01% |
106,698
-37,005
| -26% | -$1.2M |
|
727
Envista
NVST
$3.45B
| $3.47M | 0.01% |
124,306
-59,733
| -32% | -$1.67M |
|
728
Carpenter Technology
CRS
$12.3B
| $3.41M | 0.01% |
50,725
-1,316
| -3% | -$88.4K |
|
729
Levi Strauss
LEVI
$8.59B
| $3.4M | 0.01% |
250,339
-222,737
| -47% | -$3.02M |
|
730
NextDecade
NEXT
$2.12B
| $3.39M | 0.01% |
+661,800
| New | +$3.39M |
|
|
AUGX
731
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $3.35M | 0.01% |
650,000
-1,233,905
| -65% | -$6.35M |
|
|
ERF
732
DELISTED
Enerplus Corporation
ERF
| $3.29M | 0.01% |
+186,400
| New | +$3.29M |
|
|
TSBX
733
DELISTED
Turnstone Biologics
TSBX
| $3.28M | 0.01% |
+833,333
| New | +$3.28M |
|
734
LPL Financial
LPLA
$27.4B
| $3.28M | 0.01% |
13,800
-44,100
| -76% | -$10.5M |
|
735
Sony
SONY
$171B
| $3.25M | 0.01% |
197,430
-5,921,500
| -97% | -$97.6M |
|
736
Huntington Bancshares
HBAN
$25.8B
| $3.25M | 0.01% |
312,383
-1,769,357
| -85% | -$18.4M |
|
737
GXO Logistics
GXO
$5.76B
| $3.21M | 0.01% |
+54,662
| New | +$3.21M |
|
738
Black Diamond Therapeutics
BDTX
$183M
| $3.2M | 0.01% |
1,115,000
-885,000
| -44% | -$2.54M |
|
|
TELL
739
DELISTED
Tellurian Inc.
TELL
| $3.17M | 0.01% |
+2,733,900
| New | +$3.17M |
|
740
Playtika
PLTK
$1.39B
| $3.16M | 0.01% |
328,149
-1,093,144
| -77% | -$10.5M |
|
|
CMPS
741
Compass Pathways
CMPS
$485M
| $3.13M | 0.01% |
+423,100
| New | +$3.13M |
|
742
Jones Lang LaSalle
JLL
$14.6B
| $3.12M | 0.01% |
22,073
+16,573
| +301% | +$2.34M |
|
743
Matador Resources
MTDR
$6.16B
| $3.05M | 0.01% |
51,316
-530,342
| -91% | -$31.5M |
|
744
Skyward Specialty Insurance
SKWD
$1.93B
| $3.05M | 0.01% |
111,360
-221,911
| -67% | -$6.07M |
|
745
Esperion Therapeutics
ESPR
$524M
| $3.04M | 0.01% |
3,097,852
-1,877,148
| -38% | -$1.84M |
|
746
Taysha Gene Therapies
TSHA
$887M
| $2.96M | 0.01% |
+936,550
| New | +$2.96M |
|
|
INZY
747
DELISTED
Inozyme Pharma
INZY
| $2.94M | 0.01% |
+700,000
| New | +$2.94M |
|
748
Portland General Electric
POR
$4.63B
| $2.93M | 0.01% |
+72,300
| New | +$2.93M |
|
749
UroGen Pharma
URGN
$884M
| $2.91M | 0.01% |
+207,733
| New | +$2.91M |
|
750
Delcath Systems
DCTH
$389M
| $2.91M | 0.01% |
+717,722
| New | +$2.91M |
|